SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-049251
Filing Date
2017-09-22
Accepted
2017-09-22 16:17:01
Documents
8
Period of Report
2017-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v475578_8k.htm 8-K 28075
2 EXHIBIT 10.1 v475578_ex10-1.htm EX-10.1 203374
3 EXHIBIT 10.2 v475578_ex10-2.htm EX-10.2 99540
4 EXHIBIT 10.3 v475578_ex10-3.htm EX-10.3 77877
5 EXHIBIT 99.1 v475578_ex99-1.htm EX-99.1 11732
6 GRAPHIC image_001.jpg GRAPHIC 27714
7 GRAPHIC image_003.jpg GRAPHIC 17828
8 GRAPHIC image_002.jpg GRAPHIC 746
  Complete submission text file 0001144204-17-049251.txt   485965
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 171097793
SIC: 2834 Pharmaceutical Preparations